President’s Cancer Panel Issues Urgent Call to Increase HPV Vaccination

“Achieving widespread HPV (human papillomavirus) vaccination is one of the most profound opportunities for cancer prevention,” according to the President’s Cancer Panel. Hager Sharp is honored to support the release of the Panel’s 2012-2013 report, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer.  National coverage included USA TODAY, The New York Times, HealthDay, CBS Radio News, and American Urban Radio Network, among others.

One in four people in the U.S. are infected with at least one type of HPV, a group of viruses linked to multiple cancers and other diseases. The Centers for Disease Control and Prevention estimates that increasing HPV vaccination rates from current levels to 80 percent would prevent an additional 53,000 future cervical cancer cases in the U.S. among girls who now are 12 years of age or younger, over the course of their lifetimes.  Thousands of cases of other HPV-associated cancers in the U.S., a growing proportion of which will occur in males, also likely would be prevented within the same timeframe.

“Being able to prevent some cancers through HPV vaccination—and forego the emotional, physical, and financial costs of treatment—is a huge success,” said Interim CEO Lynne Doner Lotenberg. “We are pleased to help share this critical call to action with key stakeholders, health care professionals, and the general public, especially parents of adolescents.”

Since 2000, Hager Sharp has provided communications and media relations support to the President’s Cancer Panel, the three-member advisory board appointed by the President of the United States.  The Panel’s mission is to monitor the development and execution of the activities of the National Cancer Program and report directly to the president.  Each year, the Panel selects an aspect of the National Cancer Program to examine and seeks input from a range of experts and cancer survivors at meetings held around the country.  The Panel then develops a formal report outlining key findings and recommendations and delivers it to the president, congressional leaders, and the directors of the National Institutes of Health and the National Cancer Institute. Hager Sharp has planned and implemented a national media strategy for the report’s release each year for more than a decade, this year adding strategic counsel and content for the Panel’s Twitter presence.

Source: Hager Sharp News

Comments are closed.